Macrophages carrying extra mitochondria helped repair nerve myelin — in rats

Edited by Samael A. Tejada, Founder & Editor-in-Chief

Mitochondrial transfer — one cell donating its powerhouses to another — keeps moving from curiosity to mechanism. Here the donation ran through an epigenetic switch: transferred mitochondria changed which genes Schwann cells could switch on, and the gene was for making cholesterol, myelin's building material.

How did the transferred mitochondria drive repair?

The team constructed macrophages loaded with transferred mitochondria, which showed an enhanced M2 reparative phenotype and metabolic activity. Once delivered, the macrophages transferred mitochondria onward to Schwann cells — the cells that wrap nerves in myelin. In Schwann cells, that raised acetyl-CoA levels, increased the activating histone mark H3K27ac at the promoter of FDFT1 (a cholesterol-synthesis gene), and upregulated cholesterol biosynthesis.

What proved the chain was causal?

Blocking either step broke the benefit: inhibiting histone acetylation or cholesterol synthesis impaired Schwann-cell repair and erectile-function recovery, while supplementing squalene, a cholesterol precursor, reversed those impairments. In the injured rats, MTM treatment significantly restored erectile function, preserved cavernous tissue structure, and promoted myelination and axonal regeneration of the injured nerve.

What would this need before it helps patients?

A manufactured cell therapy would need safety, dosing, durability and manufacturing work, then human trials — none of which exists yet. The authors frame the mitochondrial-epigenetic-lipid axis as a promising strategy for cavernous nerve injury and, speculatively, other demyelinating disorders. That broader claim is a hypothesis from one rat study, not a demonstrated result.

Where the evidence stands

• Established: Schwann cells build myelin, cholesterol is an essential myelin component, macrophages can adopt reparative phenotypes, and intercellular mitochondrial transfer occurs in injured tissues.
• Preliminary: In a rat cavernous-nerve-injury model (Cell & Bioscience, Oct 24, 2026), mitochondria-transferred macrophages donated mitochondria to Schwann cells, driving an acetyl-CoA / H3K27ac / FDFT1 cholesterol pathway that supported myelin repair and restored erectile function; blocking acetylation or cholesterol synthesis impaired recovery.
• Absent: Human data of any kind, and any evidence in other demyelinating diseases.